• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AIKI

AIKI

AIkido Pharma Inc.

NASDAQHealthcareBiotechnologyUS

USD3.56

+0.03 (+0.85%)

Company Profile

CEO

Anthony C. Hayes

IPO Date

1980-03-18

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.55

Prev. Close

$3.53

Day Low

$3.50

Day High

$3.66

52W Low

$0.29

52W High

$7.27

Market Cap

$0.02B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.7%

Avg Negative

1.9%

Avg Neutral

65.4%

News Feed

Notice of Allowance Issued for Central Nervous System Peptide Technology

PRNewsWire·7/27/2021·↓ negative

AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland

PRNewsWire·7/16/2021·↑ positive

AIkido Pharma to Attend the Alzheimer's Association International Conference

PRNewsWire·7/13/2021·↑ positive

AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease

PRNewsWire·6/23/2021·↑ positive

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

PRNewsWire·6/4/2021·↑ positive

AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash

Newsfile Corp·5/20/2021·↑ positive

AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Meeting

PRNewsWire·5/20/2021·↑ positive

7 Reddit Penny Stocks Promising to Cure Cancer

InvestorPlace·5/14/2021·↑ positive

AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives

Newsfile Corp·5/13/2021·↑ positive

AIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate Update

PRNewsWire·5/11/2021·↑ positive